Block listing Interim Review

About this update from Oxford Biomedica Plc

Name of  applicant : OXFORD BIOMEDICA PLC Name of scheme: 2015 Employee Share Option Scheme Period of return: From: 1 January 2025 To: 30 June 2025 Balance of unallotted securities under scheme(s) from previous return: 283,522 Plus:     The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL Less:     Number of  securities  issued/allotted under scheme(s) during period (see LR3.5.7G): 2,686 Equals:     Balance under scheme(s) not yet issued/allotted at end of period: 280,836     Name of  applicant : OXFORD BIOMEDICA PLC Name of scheme: 2015 and 2024 Long Term Incentive Plan Period of return: From: 1 January 2025 To: 30 June 2025 Balance of unallotted securities under scheme(s) from previous return: 560,726 Plus:     The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 550,000 Less:     Number of  securities  issued/allotted under scheme(s) during period (see LR3.5.7G): 120,497 Equals:     Balance under scheme(s) not yet issued/allotted at end of period: 990,229                     Name of  applicant : OXFORD BIOMEDICA PLC Name of scheme: 2015 and 2024 Deferred Bonus Plan Period of return: From: 1 January 2025 To: 30 June 2025 Balance of unallotted securities under scheme(s) from previous return: 375,061 Plus:     The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 200,000 Less:     Number of  securities  issued/allotted under scheme(s) during period (see LR3.5.7G): 52,612 Equals:     Balance under scheme(s) not yet issued/allotted at end of period: 522,449       Name of  applicant : OXFORD BIOMEDICA PLC Name of scheme: Sharesave Scheme Period of return: From: 1 January 2025 To: 30 June 2025 Balance of unallotted securities under scheme(s) from previous return: 339,040 Plus:     The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL Less:     Number of  securities  issued/allotted under scheme(s) during period (see LR3.5.7G): NIL Equals:     Balance under scheme(s) not yet issued/allotted at end of period: 339,040   Name of contact: Natalie Walter, Company Secretary Telephone number of contact: 01865 783000  

View stock analysis, news, and events for Oxford Biomedica Plc